New Drug Application News and Research

RSS
MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

Bristol-Myers Squibb submits New Drug Application to the U.S. Food and Drug Administration for entecavir

Bristol-Myers Squibb submits New Drug Application to the U.S. Food and Drug Administration for entecavir

New drug application to market ramelteon for insomnia

New drug application to market ramelteon for insomnia

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

New drug application for exenatide has been accepted for review

New drug application for exenatide has been accepted for review

MGI PHARMA acquires Aesgen for $32 million

MGI PHARMA acquires Aesgen for $32 million

Kiwis reverse heart disease in diabetics

Kiwis reverse heart disease in diabetics

No adverse side-effects have been observed in clinical trial of SARS vaccine

No adverse side-effects have been observed in clinical trial of SARS vaccine

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

FDA approval for mint flavor nicotine gum

FDA approval for mint flavor nicotine gum

New Drug Application with the U.S. Food and Drug Administration for Tarceva

New Drug Application with the U.S. Food and Drug Administration for Tarceva

Plan B has been shown to reduce the risk of pregnancy by 89 percent

Plan B has been shown to reduce the risk of pregnancy by 89 percent

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

Alcon updates filing status of RETAANE® new drug application

Alcon updates filing status of RETAANE® new drug application

Exelixis files new drug application for a proprietary novel anticancer compound

Exelixis files new drug application for a proprietary novel anticancer compound

FDA finds gepirone ER “not approvable” as a treatment for Major Depressive Disorder

FDA finds gepirone ER “not approvable” as a treatment for Major Depressive Disorder